1. Home
  2. Analysis
  3. Atorvastatin-calcium
  4. Shock-haemorrhagic

Atorvastatin calcium and Shock haemorrhagic - a phase IV clinical study of FDA data

Summary:

Shock haemorrhagic is reported as a side effect among people who take Atorvastatin calcium (atorvastatin calcium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have Dyslipidaemia.

The phase IV clinical study analyzes which people have Shock haemorrhagic when taking Atorvastatin calcium. It is created by eHealthMe based on reports of 72,753 people who have side effects when taking Atorvastatin calcium from the FDA, and is updated regularly.

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,309 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.

What is Shock haemorrhagic?

Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding) is found to be associated with 655 drugs and 799 conditions by eHealthMe. Check the latest studies of Shock haemorrhagic.

On Jul, 27, 2026

72,753 people reported to have side effects when taking Atorvastatin calcium.
Among them, 51 people (0.07%) have Shock haemorrhagic.

Could Atorvastatin calcium cause Shock haemorrhagic?

Among these 51 people:

How long have people been on Atorvastatin calcium when they have Shock haemorrhagic? *

  • < 1 month: 54.55 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 18.18 %
  • 2 - 5 years: 27.27 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Shock haemorrhagic when taking Atorvastatin calcium? *

  • female: 42.86 %
  • male: 57.14 %

What is the age of people who have Shock haemorrhagic when taking Atorvastatin calcium? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.08 %
  • 40-49: 6.25 %
  • 50-59: 10.42 %
  • 60+: 81.25 %

What are other drugs people take besides Atorvastatin calcium? *

  1. Bisoprolol Fumarate: 10 people, 19.61%
  2. Plavix: 10 people, 19.61%
  3. Pantoprazole: 10 people, 19.61%
  4. Aspirin: 8 people, 15.69%
  5. Omeprazole: 7 people, 13.73%
  6. Eliquis: 7 people, 13.73%
  7. Lasix: 7 people, 13.73%
  8. Lovenox: 6 people, 11.76%
  9. Vitamin B12: 5 people, 9.80%
  10. Ramipril: 5 people, 9.80%

What are other side effects people have besides Shock haemorrhagic? *

  1. Haematoma (collection of blood outside the blood vessels): 10 people, 19.61%
  2. Anaemia (lack of blood): 7 people, 13.73%
  3. Weakness: 6 people, 11.76%
  4. Septic Shock (shock due to blood infection): 5 people, 9.80%
  5. Cancer Pain: 4 people, 7.84%
  6. Haematemesis (vomiting of blood): 4 people, 7.84%
  7. Melaena (the passage of black, tarry stools): 4 people, 7.84%
  8. Rectal Haemorrhage (bleeding from anus): 4 people, 7.84%
  9. Multi-Organ Failure (multisystem organ failure): 3 people, 5.88%
  10. Bradycardia (abnormally slow heart action): 3 people, 5.88%

What are the existing conditions these people have? *

  1. Dyslipidaemia (abnormal amount of lipids): 13 people, 25.49%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 17.65%
  3. Type 2 Diabetes: 7 people, 13.73%
  4. Diabetes: 7 people, 13.73%
  5. Constipation: 5 people, 9.80%
  6. Cancer Pain: 4 people, 7.84%
  7. Cardiomyopathy (weakening of the heart muscle): 4 people, 7.84%
  8. Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 4 people, 7.84%
  9. Non-Small Cell Lung Cancer Stage Iv: 4 people, 7.84%
  10. Hypertriglyceridaemia (excess of triglycerides in the blood): 4 people, 7.84%

* Approximation only. Some reports may have incomplete information.

Do you take Atorvastatin calcium and have Shock haemorrhagic?

- Check whether Shock haemorrhagic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atorvastatin calcium:

Shock haemorrhagic treatments and more:

How severe was Shock haemorrhagic and when was it recovered:

Expand to all the drugs that have ingredients of atorvastatin calcium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atorvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Shock haemorrhagic:

Browse all the conditions that are associated with Shock haemorrhagic:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium (the active ingredients of Atorvastatin calcium) and Atorvastatin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.